Debnox PM 2mg/500mg/15mg Tablet
Marketer
Magma Allianz Laboratories Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Debnox PM 2mg/500mg/15mg Tablet
GlycoBalance PM 2mg/500mg/15mg tablets combine medications to effectively manage blood glucose. This formulation, used alongside diet and exercise, optimizes blood sugar control in adult patients with type 2 diabetes. It enhances insulin efficiency, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for GlycoBalance PM tablets; consume with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, omit the missed dose and resume your regular schedule. Never double the dose. Excessive intake can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician. Renal function will be assessed by your doctor before treatment begins. Limit alcohol consumption, as this may heighten the probability of adverse reactions.
Primary Ingredients of Debnox PM 2mg/500mg/15mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Debnox PM 2mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Debnox PM 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Debnox PM 2mg/500mg/15mg tablet whole; do not fracture, pulverize, or chew it. Administer this medication with food.
Common Side effects of Debnox PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Debnox PM 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Debnox PM 2mg/500mg/15mg tablets with food.
How Debnox PM 2mg/500mg/15mg Tablet works:
Debnox PM tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Debnox PM 2mg/500mg/15mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Debnox PM 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Debnox PM 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Scant available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Debnox PM 2mg/500mg/15mg tablets, as dose modification may be necessary. Medical consultation is recommended. The use of Debnox PM 2mg/500mg/15mg tablets is contraindicated in individuals with severe kidney disease. Kidney function should be regularly monitored during treatment.
LiverCAUTION
Patients with liver impairment should use Debnox PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of Debnox PM 2mg/500mg/15mg tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Debnox PM 2mg/500mg/15mg Tablet :
Should you forget to take your Debnox PM 2mg/500mg/15mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Debnox PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Medication |
3,018 People bought this recently